Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis.
T Rifki
TR
Evrenkaya
Enes M
EM
Atasoyu
Suat
S
Unver
Cinar
C
Basekim
Huseyin
H
Baloglu
M Yasar
MY
Tulbek
D000438:Alcohols / Q000009:adverse effects; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002710:Chlorhexidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003902:Detergents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000295:instrumentation*; D010538:Peritonitis; D011239:Prednisolone; D012598:Sclerosis; D013629:Tamoxifen
D000438:Alcohols; D003902:Detergents; D007166:Immunosuppressive Agents; D013629:Tamoxifen; D011239:Prednisolone; C010882:chlorhexidine gluconate; D002710:Chlorhexidine